TY - JOUR
T1 - Cardiopulmonary response to vasopressin-induced activation on V 1A receptors in the lateral ventrolateral medulla in the rat
AU - Cheng, Meng Tzu
AU - Chuang, Ching Wen
AU - Lin, Jin Tun
AU - Hwang, Ji Chuu
PY - 2004/3/31
Y1 - 2004/3/31
N2 - The aim of the study was to examine whether or not arginine vasopressin (AVP) might modulate cardiopulmonary functions by acting on the lateral area of the ventrolateral medulla (VLM) in the rat. The rat was anesthetized, bilaterally vagotomized, paralyzed, ventilated, and then placed on a stereotaxic instrument in a prone position. Activity of the phrenic nerve (PNA) was monitored at normocapnia and hypercapnia in hyperoxia. Microinjection of AVP into the lateral region of the VLM resulted in a brief apnea followed by a significant decrease in PNA amplitude and a concomitant significant increase in blood pressure. The inhibition of PNA with AVP treatment could be partly attenuated by hypercapnia but not by phentolamine. Both inhibition of PNA and pressor response with AVP microinjection into the lateral VLM were totally abolished after pretreatment with AVP V 1A receptor antagonist. These results suggest that a vasopressinergic pathway projects to the lateral VLM and modulates cardiopulmonary functions via AVP V 1A receptors on neurons within the lateral VLM.
AB - The aim of the study was to examine whether or not arginine vasopressin (AVP) might modulate cardiopulmonary functions by acting on the lateral area of the ventrolateral medulla (VLM) in the rat. The rat was anesthetized, bilaterally vagotomized, paralyzed, ventilated, and then placed on a stereotaxic instrument in a prone position. Activity of the phrenic nerve (PNA) was monitored at normocapnia and hypercapnia in hyperoxia. Microinjection of AVP into the lateral region of the VLM resulted in a brief apnea followed by a significant decrease in PNA amplitude and a concomitant significant increase in blood pressure. The inhibition of PNA with AVP treatment could be partly attenuated by hypercapnia but not by phentolamine. Both inhibition of PNA and pressor response with AVP microinjection into the lateral VLM were totally abolished after pretreatment with AVP V 1A receptor antagonist. These results suggest that a vasopressinergic pathway projects to the lateral VLM and modulates cardiopulmonary functions via AVP V 1A receptors on neurons within the lateral VLM.
KW - AVP V -receptor antagonist
KW - Arginine vasopressin
KW - Blood pressure
KW - Hypercapnia
KW - Phrenic nerve activity
KW - Rat
KW - Ventrolateral medulla
UR - http://www.scopus.com/inward/record.url?scp=1642444666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1642444666&partnerID=8YFLogxK
M3 - Article
C2 - 15239592
AN - SCOPUS:1642444666
SN - 0304-4920
VL - 47
SP - 31
EP - 42
JO - Chinese Journal of Physiology
JF - Chinese Journal of Physiology
IS - 1
ER -